When it comes to cancer recovery, surgery, chemotherapy, radiotherapy, and nutritional support often take center stage. But there’s an often-overlooked factor that can quietly undermine progress: heavy metal accumulation in the body. These invisible toxins may impair your body’s ability to repair, weaken immunity, and interfere with post-treatment recovery strategies.
Vascular health is one of the most crucial, yet often overlooked, foundations of overall wellness. Conditions like atherosclerosis, coronary artery disease, and stroke don’t develop overnight—they are the result of long-term vascular damage that often goes unnoticed until it becomes serious.
PlaqX Forte offers a unique, science-backed approach to restoring vascular flexibility and supporting long-term heart and circulatory health. Instead of merely managing symptoms, it targets the underlying deterioration of blood vessels—offering early support before major issues arise.
In modern society, more and more people are realizing the importance of regular health checkups. The purpose of these checkups is no longer just to identify potential health problems, but rather to help us detect risks early, monitor our bodily functions, and intervene in time. Regular checkups allow you to better understand your body and ensure your health remains under control.
In addition to common checkup items like blood pressure and weight, specialized tests can help us gain more precise insights into various bodily functions. For instance, liver and kidney function tests, blood lipids, and thyroid function assessments can help us detect potential disease risks and take action in time.
When it comes to cancer and nutritional support, glutathione is often a recurring name. Known as one of the body’s most powerful endogenous antioxidants, it is commonly associated with benefits such as “free radical scavenging,” “cell protection,” and “reducing side effects of chemotherapy.”
But did you know? Antioxidation is only part of glutathione’s role. Its true impact in cancer support care goes far beyond what most people assume.
Your scans may look clear, but are you really in the clear?
After surgery, chemotherapy, or radiation, many cancer survivors undergo routine CT, MRI, or tumor marker tests. When results come back “normal,” it’s a huge relief—but can also lead to a false sense of security.
In truth, numerous studies suggest that microscopic cancer cells may still linger in the body—dormant, hidden, and waiting for the right conditions to reactivate. This is why post-cancer monitoring needs to go beyond conventional imaging, and why emerging tools like those developed by RGCC offer deeper insight into real-time recurrence risk.
After completing cancer treatment, many patients seek to boost recovery with nutritional support. Among these, albumin is often regarded as a key indicator of nutritional status and physical strength. However, did you know that not all methods of supplementing albumin are suitable for a post-cancer body? If done incorrectly, it could actually place added stress on the liver and kidneys.
In a fast-paced city like Hong Kong, many people live close to MTR stations or in older buildings. While these locations offer convenience, they can also pose hidden health risks—especially due to long-term exposure to heavy metals such as lead, arsenic, and mercury. These harmful substances often originate from industrial emissions, traffic pollution, and outdated construction materials, potentially impacting your body without obvious symptoms.
For many cancer patients, follow-up often means regularly scheduled CT or MRI scans, hoping to catch signs of recurrence early. But what if these imaging tools are only showing part of the picture? In truth, most imaging technologies only detect tumors once they’ve reached a certain size. When it comes to predicting whether cancer will return—or whether it might develop in the first place—conventional scans may not tell the whole story.
This is where newer tools, such as Onco-D-clare by RGCC, provide added value. Rather than detecting cancer that has already formed, this test evaluates your internal risk profile on a genetic and molecular level. It’s a proactive way to personalize your prevention strategy.
You prepare every meal. You remind them to take their medications. You show up for every appointment.
Still, you hear:
“I’m exhausted.”
“I can’t eat.”
“I feel worse.”
If you’ve ever felt helpless despite giving your all, you’re not alone.
For many people undergoing cancer treatment, these symptoms—fatigue, loss of appetite, poor sleep—are not just side effects. They become part of everyday life.
When standard treatment focuses solely on targeting the cancer, it often overlooks what the body and mind need to recover. This is where supportive care becomes more than comfort—it becomes essential.
Why RGCC CTC Testing May Reveal the Hidden Risks Still Lurking in Your Body
For many people, the end of cancer treatment marks the end of their journey—often celebrated as a full recovery. But the truth is, cancer doesn’t always end when chemotherapy, surgery, or radiation do. Research increasingly shows that small numbers of cancer cells may remain dormant in the body, quietly waiting for the right moment to resurface. This is why, even years after completing treatment, patients can still face recurrence or metastasis.
So how can we detect these “invisible threats” that evade standard tests? This is exactly where RGCC CTC (Circulating Tumor Cell) testing comes in—a cutting-edge tool designed to identify residual cancer activity before it becomes a visible problem.